IPO market stir, five pharmaceutical companies are bringing IPO this month, expected to raise more than 8,000 crores
Five pharmaceutical companies in the next few weeks, seeing huge investor interest in the healthcare sector initial public offering (IPO) will raise funds of more than Rs 8,000 crore. The list includes Rs 4,000 crore IPO of Bain Capital-backed Emcure Pharma, Rs 1,500 crore IPO of Vijaya Diagnostic Centre, Rs 1,200 crore IPO of Krishna Diagnostics, Rs 1,200 crore IPO of Mumbai-based wholesale drug maker Supriya Lifesciences, and Windlass. Biotech’s Rs 400 crore IPO is involved.
Investment bankers estimate that these five companies could take a combined public offering of over Rs 8,300 crore this month.
According to the data available with the stock exchanges, so far this financial year 12 companies have raised Rs 27,000 crore from IPOs and more IPOs worth Rs 70,000 crore are in process. In contrast, in the entire financial year 2020-21, only 30 IPOs raised Rs 31,277 crore.
Apart from these pharmaceutical companies, the IPOs of Devyani International and Exxaro Tiles are opening on August 4. Also, issues of consumer-centric companies like Paytm, MobiKwik, Policybazaar, Cartrade, Delhivery and Nykaa will also open soon. According to market experts, 40 more IPOs are in line for the rest of the year, trying to raise Rs 70,000 crore.
In the first four months of the current financial year, 12 companies have raised Rs 27,052 crore through IPOs.